CORONA Remedies Limited conducted its 22nd Annual General Meeting (AGM) on Thursday, July 09, 2026, via Video Conferencing / Other Audio Visual Means. The meeting commenced at 11:00 a.m. and concluded at 11:45 a.m. During the AGM, several key resolutions were passed through remote e-voting. These included the adoption of Audited Financial Statements (Standalone and Consolidated) for the financial year ended March 31, 2026, and the Reports of the Board of Directors and Auditors. A final dividend of ₹ 10 per Equity Share (100%) for the Financial Year 2025-26 was declared. Other approved resolutions pertained to the re-appointment of Mr. Nirav Mehta, who retires by rotation, and the appointment of M/s. Walker Chandiok & Co LLP as the Statutory Auditors, along with fixing their remuneration. The remuneration payable to the Cost Auditors for FY 2026-27 was ratified. Additionally, M/s. Dhara Patel, Company Secretary Firm, was appointed as the Secretarial Auditors. The meeting also approved the payment of commission to Non-Executive Directors and the remuneration for Dr. Kirtikumar Mehta as Non-Executive Director and Chairman for FY 2026-27. Furthermore, Dr. Kirtikumar Mehta was re-appointed as Non-Executive Director and Chairman for a term of 5 years. The declaration of voting results, along with the Scrutinizer’s Report, will be disclosed separately to the Stock Exchanges. This information is also available on the company's website.
